FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

25197311000001106: Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Aug 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
80254301000001113 Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80254401000001117 Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route gel.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Is a Lidocaine + Tetracaine + Adrenaline true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has specific active ingredient Epinephrine true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has specific active ingredient Tetracaine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has active ingredient Tetracaine true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has active ingredient Epinephrine true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel 3 ml Has VMP True Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel (Special Order) Is a True Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Inferred relationship Existential restriction modifier
Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel 1 ml Has VMP True Lidocaine 4% / Tetracaine 0.5% / Adrenaline (base) 0.1% gel Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start